The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A national prospective survey of breakthrough cancer pain characteristics and treatments in France 10 years after the preliminary study (ASCO 2000).
J. F. Morere
Consultant or Advisory Role - Cephalon
P. Poulain
Consultant or Advisory Role - Cephalon
M. Filbet
Consultant or Advisory Role - Cephalon
I. Krakowski
Consultant or Advisory Role - Cephalon
A. Serrie
Consultant or Advisory Role - Cephalon
C. Delorme
Consultant or Advisory Role - Cephalon
D. Ammar
Consultant or Advisory Role - Cephalon
F. Scotte
Consultant or Advisory Role - Cephalon
V. Grange
Employment or Leadership Position - Cephalon